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Abstract PDR13 in Saccharomyces cerevisiae contributes to
drug resistance via sequential activation of PDR1 and PDR5. In
this study, we found that a PDR13 deletion mutant was
hypersensitive to Cu2+ compared to the wild-type counterpart.
The Cu2+ tolerance mechanism mediated by Pdr13 does not seem
to involve Pdr1 or Pdr5, since mutants harboring a deletion of
either the PDR1 or PDR5 gene did not show elevated Cu2+
sensitivity. Instead, we found that the PDR13 null mutant could
not express CUP1 or CRS5 metallothionein at wild-type levels
when subjected to high Cu2+ stress. These results suggest
that Pdr13 contributes to high Cu2+ tolerance of S. cerevisiae,
at least in part, via a mechanism involving metallothionein
expression. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Copper (Cu) is an essential element required by all living
organisms. However, high Cu levels are toxic, mainly because
Cu catalyzes the synthesis of reactive oxygen species that
cause cellular damage [1,2]. It is important that organisms
elaborate appropriate mechanisms for Cu uptake [3^5] and
detoxi¢cation [6,7] to ensure that su⁄cient Cu is present in
the cell to drive essential biochemical processes while prevent-
ing its accumulation to toxic levels. To tolerate high Cu levels,
yeast cells express methallothioneins (MTs), Cup1 and Crs5
[8^12]. These MTs sequester Cu ions and thus protect yeast
cells from high Cu toxicity [8,13].
From our screening of heavy metal-sensitive mutants of
Saccharomyces cerevisiae, we found that the yeast cell line
harboring a PDR13 (pleiotropic drug resistance) deletion
was more sensitive to Cu2 compared to wild-type cells.
PDR13 encodes an Hsp70 homolog that has a role in drug
resistance. Pdr13 elevates the function of Pdr1 [14], a tran-
scription factor that up-regulates the expression of PDR5 and
YOR1, genes encoding ATP-binding cassette transporters
(ABC transporter) involved in drug e¥ux [15^18]. Pdr13
may have other functions as well, since PDR13 deletion mu-
tants show elevated expression of several stress-responsive
genes, including CUP1, CTT1, HSP12 [14] and have increased
sensitivity to high-osmolarity stress [19]. The possible roles of
Pdr13 in stress responses have not been intensively investi-
gated. In this study we show that Pdr13 has a role in resis-
tance to high Cu2 stress, and that it functions not via acti-
vation of a drug resistance pathway involving Pdr1 or Pdr5,
but rather via expression of the MT genes.
2. Materials and methods
2.1. Yeast growth conditions and metal treatment
Yeast cells were grown in either YPD medium (1% yeast extract,
2% Bacto Peptone, 2% dextrose) or in synthetic complete (SC) me-
dium for selection of strains transformed with plasmids. Liquid cul-
tures were seeded to an optical density of 0.5 and grown to exponen-
tial phase at 30‡C and 200 rpm. Harvested yeast cells were grown on
1/2 YPD or 1/2 SC agar medium (1U YPD or SC broth diluted with
an equal volume of 3% microagar) containing the indicated concen-
trations of CuCl2 or CdCl2.
2.2. Construction of plasmids and yeast strains
The genotypes of the yeast strains used in this study were SEY6210
(MATK leu2-3,112ura3-52 lys2-801 trp1-v901 his3-v200 suc2-v9
Mel3) and Y800 (MATK leu2-v98 CRY1 ade2-101 his3-v200 ura3-
52 CAN1 lys2-801 cyh2R TRP1). PDR1, PDR5, PDR13 null mutants
and their isogenic wild-type strain (SEY6210) were kindly provided by
Dr. W.S. Moye-Rowley. Yeast cells were transformed using the lith-
ium-acetate method [20]. A 3.2-kb fragment containing the PDR13
open reading frame was ampli¢ed by PCR using gene speci¢c primers
PDR13-F (5P-CCGTCGACTATGACTT CCAAAATTGATAAAT-
TACAAAG-3P) and PDR13-R (5P-CGAATCGAAATGTTGTTCC-
CATTTGTCTTC-3P). The ampli¢ed DNA was cloned into the YC-
plac33 (single-copy) and YEplac195 (multi-copy) vectors [21], which
were named YCplac-PDR13 and YEplac-PDR13, respectively. YC-
plac33 and YEplac195 vectors were kindly provided by Dr. S.H.
Leem. For overexpression of CUP1 gene in PDR13 null mutant
(vpdr13), CUP1 gene was PCR-ampli¢ed using an N-terminus primer
5P-CATCACATAAAATGTTCAGC-3P and a C-terminus primer 5P-
CCGGTACCGACGTTCTCATAATAC-3P, cloned into the pYES2
vector (Invitrogen), and then transformed into vpdr13 yeast cells.
For expression of CUP1 gene, the cells were grown on 1/2 SC agar
medium in which galactose substituted for dextrose.
2.3. Chromosomal deletion of the PDR13 gene
The chromosomal PDR13 gene was replaced with URA3. The
PDR13-containing pGEM T-easy vector was cleaved by HindIII,
which resulted in PDR13-£anking sequences from 220 to 1330, and
ligated with URA3 derived from pRS316 [22]. The PCR-ampli¢ed
PDR13^URA3 construct was transformed into wild-type cells
(Y800) by the lithium-acetate method. URA3 transformants were se-
lected, and correct integration was con¢rmed by PCR.
2.4. Measurements of cellular Cu levels
Yeast strains were cultured on YPD agar plates for 1 day at 30‡C,
transferred to metal-containing 1/2 YPD agar plates, cultured for
1 day at 30‡C, and then harvested. They were washed twice in ice-
cold 1 mM citrate solution for 30 min each. Cells were brie£y centri-
fuged, collected, and digested with 65% HNO3 at 200‡C for 6 h.
Digested samples were diluted with 0.5 N HNO3 and analyzed using
an atomic absorption spectrometer (AAS; SpectrAA-800, Varian).
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2.5. RNA extraction and Northern blot analysis
Total RNA was prepared from exponentially growing cells under
conditions indicated in the ¢gure legends. 30 Wg of total RNA was
separated in a formaldehyde-containing agarose gel and then trans-
ferred onto nylon membranes. After UV crosslinking, hybridization
was carried out in 6USSPE, 0.5% SDS, 1% non-fat milk and 50%
formamide at 42‡C for 16 h with 32P-labeled gene probes. The hy-
bridized membrane was exposed to a phosphorimager screen (Fuji
¢lm) or X-ray ¢lm (Kodak). The mRNA expression levels were ana-
lyzed by the Mac-BAS image-reader program.
3. Results
3.1. Involvement of Pdr13 in tolerance to high copper and
cadmium levels
The PDR13 null mutant (vpdr13), which grew to similar
cell numbers as its isogenic wild-type after three days of
growth in control YPD medium (Fig. 1A), showed a more
sensitive phenotype than the wild-type strain when grown in
1/2 YPD agar plates containing 4.5 mM or higher concentra-
tions of Cu2 (Fig. 1B). The null mutant was also more sen-
sitive to Cd2 (50 WM) than the wild-type strain (Fig. 1C).
However, the mutant did not show elevated sensitivity to
Pb2, Ni2 or Zn2 (data not shown). The Cu2-sensitive
phenotype of the mutant was consistently strong, and thus
we decided to concentrate our studies on the mechanism of
Cu2 sensitivity in this mutant.
To con¢rm that the Cu2-sensitive phenotype of vpdr13
was indeed due to the deletion of PDR13, we transformed
the vpdr13 strain with low copy- and high copy-number plas-
mids carrying the PDR13 gene. In both cases, vpdr13 yeast
cells transformed with PDR13-containing plasmids recovered
the phenotype of the wild-type strain, while the same strain of
cells transformed with empty vectors failed to do so (data not
shown). However, there was no di¡erence in Cu2 resistance
between low- and high-copy number PDR13-plasmid trans-
formants (data not shown).
3.2. Cu2+ and Cd2+ elevate PDR13 mRNA levels
We tested whether Cu2 and Cd2 could induce the expres-
sion of the PDR13 gene in wild-type S. cerevisiae. The level of
PDR13 transcript was increased by 2.6 fold by Cu2 and 1.9
fold by Cd2 treatments at concentrations that inhibit growth
by 30^40% in YPD-liquid medium (data not shown).
3.3. Cu2+ detoxi¢cation by PDR13 is not via the
drug resistance pathway
Pdr13 has been reported to elevate the function of Pdr1, a
protein that regulates the expression of ABC transporter-en-
coding genes (PDR5 and YOR1), which are required for nor-
mal cycloheximide and oligomycin tolerance [14,17,18]. To
examine whether Pdr13 also requires Pdr1 and Pdr5 for
high Cu2 tolerance, we tested the phenotypes of the PDR1
and PDR5 null mutants in media containing 4.5 mM Cu2.
The PDR1 and PDR5 null mutants were no more sensitive to
high Cu2 concentrations than the wild-type (Fig. 2). These
results suggest that the PDR1 and PDR5 multi-drug resistance
genes are not involved in the Cu2-detoxifying mechanism
mediated by Pdr13.
3.4. Cellular Cu content ofvpdr13 is lower than that of
wild-type cells
When Cu2 is accumulated in excess, it is toxic due to its
propensity to participate in Fenton-like reactions that lead to
the generation of highly reactive hydroxyl radicals that cause
cellular damage. We measured Cu levels in wild-type cells and
the vpdr13 strain to see whether the mutant had higher levels
of cellular Cu leading to its more sensitive phenotype.
In contrast to our prediction, a much lower level of cellular
Cu was detected in the vpdr13 strain than in wild-type cells
when exposed to YPD-agar media containing 5 mM Cu2
(Fig. 3). At lower concentrations of Cu2, no consistent di¡er-
ence in cellular Cu2 levels between the two lines was evident.
Similarly, the Cu2-sensitive phenotype only appeared when
Cu2 concentrations above 4.5 mM were added to the YPD-
agar medium, at which point the vpdr13 strain became more
Fig. 1. The vpdr13 strain is more sensitive to Cu2 and Cd2 than
wild-type cells. Yeast cells were grown in YPD medium to an
OD600 = 2. Cells were then diluted, spotted onto the indicated metal-
containing 1/2 YPD plate, and grown for 3 days. Two strains of
yeast were used to test Cu2 sensitivity. Lanes 1 (SEY6210) and 3
(Y800) are wild-type cells, and 2 and 4 are vpdr13 strains of
SEY6210 and Y800 cells, respectively. (A) Control medium, (B) 4.5
mM Cu2-containing medium, (C) 50 WM Cd2-containing medium.
Fig. 2. The Cu2-sensitive phenotype of the vpdr13 strain is not
caused by defects in the drug resistance pathway mediated by Pdr1.
The Cu2 sensitivity was tested as described in Fig. 1. Lane 1: WT,
lanes 2, 3, 4: PDR1, PDR5, PDR13 null mutants, respectively.
(A) Control medium, (B) 4.5 mM Cu2-containing medium.
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sensitive to Cu2 than its wild-type (Fig. 1, our unpublished
data).
3.5. Changes in the expression of Cu metallothioneins
Since MTs are important for high Cu2 tolerance, we ex-
amined whether deletion of the PDR13 gene a¡ects MT gene
expression in yeast. Cup1 and Crs5 are well-known copper
MTs, which bind to cellular free Cu ions and detoxify their
toxic e¡ects [11]. When we treated the wild-type and vpdr13
strains with 4.5 mM Cu2, the di¡erence between the 2 strains
in the levels of CUP1 expression increased with time (Fig. 4).
After a 15 h treatment with 4.5 mM Cu2, CUP1 gene ex-
pression in vpdr13 cells was much lower than that in wild-type
cells. The levels of expression of the CRS5 gene were also
lower in the mutant than in wild-type yeast cells, although
its overall expression levels were much lower than those of
CUP1 (data not shown).
3.6. Overexpression of CUP1 metallothioneins in vpdr13 cells
If the reduced expression of Cu metallothionein caused the
Cu2 sensitivity of vpdr13 cells, the Cu2-sensitive phenotype
may be rescued by overexpression of CUP1, a major Cu met-
allothionein gene. Indeed, vpdr13 cells transformed with a
multi-copy vector containing CUP1 grew better than the
same line of cells transformed with empty vector on 1 mM
Cu2-containing SC-ura agar medium (data not shown).
However, vpdr13 cells overexpressing CUP1 still could not
grow as well as the wild-type cells or vpdr13 cells comple-
mented with PDR13 gene (data not shown).
4. Discussion
In this paper, we showed that Pdr13 contributes to detoxi-
¢cation of excess Cu2 in yeast. The vpdr13 strain was sensi-
tive to Cu2 and Cd2 (Fig. 1), and complementation of the
mutant cells with PDR13 recovered its Cu2 tolerance to lev-
els comparable to those of wild-type cells. We also observed
that Pdr13 is up-regulated by Cu2 and Cd2 (data not
shown), and is important for elevated MT gene expression
under high Cu2 conditions (Fig. 4), through which it confers
tolerance to excess Cu2.
Previously it has been reported that Pdr13 activates Pdr1 at
a post-translational step, resulting in increased expression of
some PDR genes, including PDR5 and YOR1 [14,23]. When
the PDR1 or PDR5 gene was deleted, yeast cells became sen-
sitive to cycloheximide and oligomycin [14,24]. However,
vpdr1 and vpdr5 strains did not show a Cu2-sensitive phe-
notype (Fig. 2). Therefore, we conclude that the Cu2 resis-
tance mechanism mediated by Pdr13 is di¡erent from multi-
drug resistance pathway mediated by Pdr1 or Pdr5.
To understand the Cu2-sensitive phenotype of vpdr13, we
measured the Cu content in wild-type and mutant cells. When
grown in medium containing 5 mM Cu2, the Cu content in
vpdr13 was about 51% of that in wild-type cells (Fig. 3). This
result indicates that tolerance to excess Cu2 mediated by
Pdr13 is not caused by the activation of a Cu2-extruding
transporter protein present in the plasma membrane. There
are two possible ways to explain why low Cu-containing mu-
tant cells showed higher sensitivity to Cu2 than their wild-
type counterparts. First, sequestration of Cu2 into vacuoles
is defective in the mutant. Vacuolar function and integrity
have been shown to be important for normal Cu2 homeo-
stasis [25], but the mechanism of sequestration of Cu2 into
vacuoles is not well understood. Second, mechanisms of Cu2
chelation are defective in the mutant. Cu MTs, Cup1 and
Crs5 are well known for their Cu2 chelating activity in bud-
ding yeasts. Therefore, we tested whether Cu MTs gene ex-
pression was altered in the mutant. Indeed, when cells were
grown in 1/2 YPD medium containing 4.5 mM Cu2, expres-
sion of both CUP1 and CRS5 MTs were lower in the mutant
compared to the control (Fig. 4, our unpublished data). In-
terestingly, when cells were grown in minimal medium without
additional Cu2, the PDR13 deletion mutant expressed higher
levels of CUP1 compared to the wild-type control ([14], our
unpublished data). Therefore, deletion of the PDR13 gene
adversely a¡ects normal regulation of the MT gene, resulting
in aberrant MT expression levels under normal and high Cu2
conditions.
To test whether the reduced expression of Cu MTs contrib-
uted to the Cu2-sensitive phenotype of vpdr13, we overex-
pressed CUP1 gene in vpdr13 cells. CUP1 gene expression
partially rescued the Cu2-sensitive phenotype of vpdr13
(data not shown). Therefore, modulation of Cu MT gene ex-
pression is one way in which Pdr13 may induce high Cu2
tolerance. Many other factors may also be involved, including
the previously-documented stress-responsive genes [14,19]. In
short, our data strongly support a role for Pdr13 in the reg-
ulation of MT gene expression, which constitutes a mecha-
nism of tolerance to excess Cu2 in S. cerevisiae.
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Fig. 3. Cellular Cu levels in the vpdr13 mutant and its isogenic
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HNO3 at 200‡C for 6 h, and analyzed for their Cu contents as de-
scribed in Materials and Methods. Data are the mean values from
three di¡erent experiments.
Fig. 4. Expression of CUP1 in the vpdr13 strain was lower than
that in wild-type cells. Exponential-phase cultures of wild-type and
vPDR13 cells were plated on 4.5 mM Cu2-containing 1/2 YPD
plates and incubated at 30‡C for the times indicated. Total RNA
was isolated as described in the Materials and Methods. Membranes
were hybridized with a CUP1 speci¢c probe labeled with [K-32P]-
dCTP and exposed to X-ray ¢lm. 18S rRNA was used as a loading
control.
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